Although for several years the intestinal inflammatory disorders, such as IBD and IBS, were considered to be neurological conditions that result from alterations in BGA, growing evidence reveals local immunological disturbances and cytokine pattern imbalances in IBD and IBS patients, boosted by peripheral CRH signaling [17,112]. This evidence concerns the gene CRH and irritable bowel syndrome.